Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad(Northwestern University), Shom Goel(Dana-Farber Cancer Institute), Jeppe Thagaard(Cyclopharma (France)), Sunil Badve(Emory University), Stuart J. Schnitt(Brigham and Women's Hospital), Johan Hartman(Karolinska University Hospital), Stephen M. Hewitt(National Institutes of Health), Yinyin Yuan(Institute of Cancer Research), Federico Rojo(Hospital Universitario Fundación Jiménez Díaz), Pawan Kirtani(Manipal Hospital), Eva Balslev(University of Copenhagen), Laura Comerma(Hospital Del Mar), Manu Sebastian(The University of Texas MD Anderson Cancer Center), Elisabeth Specht Stovgaard(University of Copenhagen), David L. Rimm(Yale University), Anant Madabhushi(Emory University), Paula I. González-Ericsson(Breast Cancer Research Foundation), Carsten Denkert(Philipps University of Marburg), Sylvia Adams(NYU Langone Health), Jennifer K. Kerner(Critical Path Institute), Marcelo Luiz Balancin(Universidade de São Paulo), Peter Savas(The University of Melbourne), Khalid AbdulJabbar(Center for Adoption Support and Education), Hugo M. Horlings, Sunil R. Lakhani(Sullivan Nicolaides Pathology), I‐Chun Chen(National Taiwan University Hospital), Jeremy Braybrooke(University Hospitals Bristol NHS Foundation Trust), Sandra Demaria(Cornell University), Christos Sotiriou(Université Libre de Bruxelles), David Moore(University College Hospital), Sarah Dudgeon(Center for Devices and Radiological Health), Jochen K. Lennerz(Addgene), Jan Hudeček(Dutch Cancer Society), Leonie Voorwerk(The Netherlands Cancer Institute), Rim S. Kim(NRG Oncology), Stephan Wienert(Charité - Universitätsmedizin Berlin), Giancarlo Pruneri(University of Milan), Elvire Roblin(Inserm), Katherine L. Pogue–Geile(NSABP Foundation), Ashish Sharma(Emory University), Giuseppe Viale(University of Milan), Weijie Chen(United States Food and Drug Administration), Andrew H. Beck(Brown University), Rajendra Singh(Icahn School of Medicine at Mount Sinai), Marie‐Christine Mathieu(Université Paris-Saclay), Frédérique Penault–Llorca(Inserm), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Mehrnoush Khojasteh(Roche (Switzerland)), Francesco Ciompi(Radboud University Nijmegen)
Cited by 168
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
|JAMA|2017|3.3k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k